Immunotherapy News and Research

Latest Immunotherapy News and Research

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

Gut bacteria may influence the response to certain cancer therapies finds study

A latest study has found that patients with advanced melanoma or skin cancer who had a specific bacteria in their gut had a more favorable response to certain types of cancer treatment or immunotherapy. The study from the University of Texas was published in the latest issue of the journal Science.

3 Nov 2017

Gut bacteria can influence how cancer responds to immunotherapy

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.

2 Nov 2017

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.

2 Nov 2017

Vedantra and Neon Therapeutics extend research alliance to develop impactful cancer therapies

Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.

31 Oct 2017

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Stand Up To Cancer, joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced today four teams of top researchers who will carry out an attack on cancers of the lung and pancreas using a radical new approach of “interception” of cancers at very early stages, when they can be more successfully treated.

31 Oct 2017

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.

31 Oct 2017

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

30 Oct 2017

Cancer researchers make breakthrough in identifying genetic changes during immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That's particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.

28 Oct 2017

Allergists look for ways to improve ‘webside manner’

How does an allergist communicate effectively with his or her patient when they're not in the same room with the person being examined? The issue of improving "webside" manner – is one topic in a panel discussion on telemedicine during the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

27 Oct 2017

Dogs may protect children from allergic eczema and asthma

"Good dog!" Two studies being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting show there may be even more reason to love your dog.

27 Oct 2017

Research: Peanut allergy in children has increased 21% since 2010

Parents often worry about peanut allergies because the reaction to peanuts can be very severe. New, late-breaking research being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting suggests that peanut allergy in children has increased 21 percent since 2010, and that nearly 2.5 percent of U.S. children may have an allergy to peanuts.

27 Oct 2017

Research: 45% of adults with food allergies develop them in adulthood

When people think of food allergies, it's mostly in relation to children. New research being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting shows that almost half of all food-allergic adults surveyed reported one or more adult-onset food allergies.

27 Oct 2017

New targeted therapies help relieve symptoms of atopic dermatitis

If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults.

27 Oct 2017

Eczema and family history linked to severe hospitalization for children with asthma

Asthma and allergies are related, and many people who suffer from asthma have allergies that trigger their asthma. Research being presented at the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting examines the relationship between medical history and allergic reactions in children, and how long they stayed in the hospital after an asthma attack.

27 Oct 2017

Study: Most pediatricians do not tell parents about early peanut introduction to prevent allergy

Guidelines to help parents introduce peanut-containing products to infants to prevent peanut allergies aren't being discussed. New research presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting shows pediatricians are not only not having the discussion, they're not referring high-risk babies for testing prior to peanut introduction.

27 Oct 2017

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

In many metastasized types of cancer, disseminated tumors grow back despite successful chemotherapy. As a research team under the direction of the University of Bern, Switzerland, has now discovered, this is because of isolated cancer cells that survive the chemotherapy due to a phase of dormancy.

27 Oct 2017

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma.

25 Oct 2017

Direct application of immune cells accelerates healing of acute, chronic wounds in mice

A Massachusetts General Hospital research team has found a surprising potential solution to a persistent clinical problem - the healing of chronic wounds. In their report published in Wound Repair and Regeneration, the investigators from the MGH Vaccine and Immunotherapy Center describe how application of mature B lymphocytes - the immune cells best known for producing antibodies - greatly accelerated the healing of acute and chronic wounds in both diabetic and nondiabetic mice.

25 Oct 2017

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse.

25 Oct 2017

Immunotherapy News and Research

Latest Immunotherapy News and Research

FDA approves first targeted cancer treatment based on basket study

Gut bacteria may influence the response to certain cancer therapies finds study

Gut bacteria can influence how cancer responds to immunotherapy

Researchers develop new, three-step system to eliminate colorectal cancer

Vedantra and Neon Therapeutics extend research alliance to develop impactful cancer therapies

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Canadian and Israeli researchers join forces for new research program

Cancer researchers make breakthrough in identifying genetic changes during immunotherapy

Allergists look for ways to improve ‘webside manner’

Dogs may protect children from allergic eczema and asthma

Research: Peanut allergy in children has increased 21% since 2010

Research: 45% of adults with food allergies develop them in adulthood

New targeted therapies help relieve symptoms of atopic dermatitis

Eczema and family history linked to severe hospitalization for children with asthma

Study: Most pediatricians do not tell parents about early peanut introduction to prevent allergy

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Direct application of immune cells accelerates healing of acute, chronic wounds in mice

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in